Patient and Proxy Recall After Providing Written or Oral Informed Consent to Participate in an Interventional Trial

JAMA Netw Open. 2022 May 2;5(5):e2214052. doi: 10.1001/jamanetworkopen.2022.14052.

Authors

Angela Huttner^{1

2}, Elodie von Dach², Virginie Prendki^{1

3}, Stephan Harbarth^{1

4}, Laurent Kaiser¹

Affiliations

¹ Division of Infectious Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
² Center for Clinical Research, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
³ Department of Rehabilitation and Geriatrics, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
⁴ Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.

Abstract

This cohort study assesses recall rates among patients and their proxies who consented to participate in a randomized clinical trial.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Advance Directives
Humans
Informed Consent*
Mental Recall
Proxy*